imdelltra: new fda-approved treatment for extensive-stage small cell lung cancer | 2024 update
Published 3 months ago • 219 plays • Length 4:06Download video MP4
Download video MP3
Similar videos
-
0:29
u.s. fda approves amgen’s targeted immunotherapy for adults w/extensive-stage small cell lung cancer
-
18:16
dellphi-301 - fda approval of tarlatamab in patients w/ prev treated small cell lung cancer (sclc)
-
0:46
new standard of care treatment for small cell lung cancer.
-
0:48
adriatic study: new standard of care treatment for small cell lung cancer
-
6:09
novel agents for r/r and the future of extensive stage sclc
-
4:26
tarlatamab: mechanism of action and clinical success in small cell lung cancer │ pharmacology
-
1:24:35
newer cancer treatment updates 2024 - 23 nov
-
19:14
aegean study - fda approval of durvalumab in resectable non-small cell lung cancer
-
6:46
tarlatamab for extensive stage small cell lung cancer- 2024 leading developments in lung cancer
-
7:05
lung cancer video library - liu - immunotherapy for small cell lung cancer
-
4:45
the skyscraper trial: treatments for extensive stage small cell lung cancer - asco lung review 2022
-
1:08:52
integrating new options into the sclc treatment arsenal to improve patient outcomes
-
18:47
lung updates | wade iams, md | 2022 west oncology conference | updates for apps and nurses
-
0:37
amgen’s tarlatamab gets fda priority review for small cell lung cancer
-
57:39
lung cancer management in north carolina: updates for 2020 - s. patel - 20200826
-
35:05
exploring the latest advances in first-line treatment of es-sclc
-
26:13
s2 episode 1: are we ready to use the word "cure" when talking about small cell lung cancer treat...
-
29:52
s1 episode 3: immunotherapy and lung cancer treatment